SCHEMBL20324729

SCHEMBL20324729

Nc1nc2c(ncn2[C@H]2CC[C@@H](CO[PH](=O)O)S2)c(=O)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPRT1 P00492 6/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ PNP P00491 4/20 0.43
▸ STING1 Q86WV6 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ BLM P54132 2/20 0.41
▸ HINT1 P49773 1/20 0.41
▸ NT5E P21589 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ EDNRA P25101 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ HBB P68871 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26196873 0.86 ADORA3 (0.48) HPRT1ADORA3PNPSTING1POLB
SCHEMBL18519687 0.86 HPRT1 (0.45) HPRT1ADORA3PNPSTING1POLB
SCHEMBL9124915 0.84 ADORA3 (0.52) HPRT1ADORA3PNPSTING1BLM
SCHEMBL9124912 0.84 ADORA3 (0.52) HPRT1ADORA3PNPSTING1BLM
SCHEMBL20324648 0.84 HPRT1 (0.48) HPRT1ADORA3PNPSTING1POLB
SCHEMBL20324698 0.83 HPRT1 (0.43) HPRT1ADORA3PNPSTING1POLB
SCHEMBL20324562 0.83 HPRT1 (0.49) HPRT1PNPPOLBNT5E
SCHEMBL20324788 0.78 ALDH1A1 (0.51) HPRT1ADORA3PNPSTING1POLB
SCHEMBL18823015 0.78 ALDH1A1 (0.51) HPRT1ADORA3PNPSTING1POLB
SCHEMBL16695875 0.76 HINT1 (0.53) ADORA3PNPSTING1POLBHINT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020205323-A1 STABLE FORMULATIONS OF CYCLIC DINUCLEOTIDE STING AGONIST COMPOUNDS AND METHODS OF USE THEREOF MERCK SHARP & DOHME CORP. (US) 2020-10-08 — — WO disclosed
WO-2018118665-A1 CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT MERCK SHARP & DOHME CORP. (US) 2018-06-28 — — WO disclosed
WO-2018118664-A1 COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT MERCK SHARP & DOHME CORP. (US) 2018-06-28 — — WO disclosed
Send feedback